Document and Entity Information - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2016 |
Feb. 15, 2017 |
Jun. 30, 2016 |
|
| Document and Entity Information | |||
| Entity Registrant Name | AMICUS THERAPEUTICS INC | ||
| Entity Central Index Key | 0001178879 | ||
| Document Type | 10-K/A | ||
| Document Period End Date | Dec. 31, 2016 | ||
| Amendment Flag | true | ||
| Amendment Description | Amicus Therapeutics, Inc. (the "Company") is filing this Amendment No. 1 ("Amendment No. 1") to its Annual Report on Form 10-K for the fiscal year ended December 31, 2016, which was originally filed with the Securities and Exchange Commission ("SEC") on March 1, 2017 (the "Original Annual Report"), for the sole purpose of correcting the number of shares of common stock outstanding as of February 15, 2017 which was reported on the cover page of the Original Annual Report. This Amendment No. 1 on Form 10-K/A continues to speak as of the date of the filing of the Original Annual Report, and the Company has not changed the financial statements nor updated the disclosures contained therein to reflect any events that occurred at a later date. | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity Well-known Seasoned Issuer | Yes | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Filer Category | Large Accelerated Filer | ||
| Entity Public Float | $ 542,291,868 | ||
| Entity Common Stock, Shares Outstanding | 142,741,036 | ||
| Document Fiscal Year Focus | 2016 | ||
| Document Fiscal Period Focus | FY |